Kohno T, Ichikawa H, Totoki Y, Yasuda Y, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, Tsuda H, Yoshida Y, Yokota J, Shibata T.
KIF5B-RET fusions in lung adenocarcinoma.
Nat Med. 18: 375-377, 2012
Suzuki Y, Mimura K, Yoshimoto Y, Watanabe M, Ohkubo Y, Izawa S, Murata K, Fujii H, Nakano T, Kono K.
Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Cancer Res. Aug 15;72(16):3967-76, 2012
Saitoh J, Saito Y, Kazumoto T, Kudo S, Yoshida D, Ichikawa A, Sakai H, Kurimoto F, Kato S, Shibuya K.
Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable, non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study.
Int J Radiat Oncol Biol Phys. Apr 1;82(5):1791-6, 2012
Wakatsuki M, Magpayo N, Kawamura H, Held KD.
Differential bystander signaling between radioresistant chondrosarcoma cells and fibroblasts after x-ray, proton, iron ion and carbon ion exposures.
Int J Radiat Oncol Biol Phys. Sep 1;84(1):e103-8, 2012
Okamoto M, Ishikawa H, Ebara T, Kato H, Tamaki T, Akimoto T, Ito K, Miyakubo M, Yamamoto T, Suzuki K, Takahashi T, Nakano T.
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.
Int J Radiat Oncol Biol Phys. Feb 1;82(2):e211-7, 2012
Oike T, Ogiwara H, Torikai K, Nakano T, Yokota J, Kohno T
Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining.
Int J Radiat Oncol Biol Phys. 84:815-821, 2012
Sakama M, Kanai T, Kase Y, Yusa K, Tashiro M, Torikai K, Shimada H, Yamada S, Ohno T, Nakano T.
Design of ridge filters for spread-out Bragg peaks with Monte Carlo simulation in carbon ion therapy.
Phys Med Biol. Oct 21;57(20):6615-33, 2012
Yamaguchi M, Torikai K, Kawachi N, Shimada H, Satoh T, Nagao Y, Fujimaki S, Kokubun M, Watanabe S, Takahashi T, Arakawa K, Kamiya T, Nakano T.
Beam range estimation by measuring bremsstrahlung.
Phys Med Biol. May 21;57(10):2843-56, 2012
Kawamura H, Ebara T, Katoh H, Tamaki T, Ishikawa H, Sakurai H, Nakano T.
Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma.
Radiat Oncol. Jul 23;7:112, 2012
Okonogi N, Hashimoto T, Ishida M, Ohno T, Terunuma T, Okumura T, Sakae T, Sakurai H.
Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation for esophageal cancer.
Radiat Oncol. Oct 19;7:173, 2012
Shirai K, Siedow MR, Chakravarti A.
Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.
J Oncol. 2012:193436, 2012
Sato Y, Ebara T, Sunaga N, Takahashi T, Nakano T.
Interaction of radiation and gefitinib on a human lung cancer cell line with mutant EGFR gene in vitro.
Anticancer Res. Nov;32(11):4877-8, 2012
Ohno T, Thinh DH, Kato S, Devi CR, Tung NT, Thephamongkhol K, Calaguas MJ, Zhou J, Chansilpa Y, Supriana N, Erawati D, Banu PA, Koo CC, Kobayashi K, Nakano T, Tsujii H.
Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia.
J Radiat Res. Nov 28. [Epub ahead of print], 2012
Ebara T, Kawamura H, Kaminuma T, Okamoto M, Yoshida D, Okubo Y, Takahashi T, Kobayashi K, Sakaguchi H, Ando Y, Nakano T.
Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma.
J Radiat Res. 2012;53(2):288-94, 2012
Harada K, Ishikawa H, Saito Y, Nakamoto S, Kawamura H, Wakatsuki M, Etsunaga T, Takezawa Y, Kobayashi M, Nakano T.
Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer.
J Radiat Res. Nov 1;53(6):923-9, 2012
Musha A, Yoshida Y, Takahashi T, Ando K, Funayama T, Kobayashi Y, Negishi A, Yokoo S, Nakano T.
Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells.
J Radiat Res. Jul;53(4):545-50, 2012
Oike T, Ohno T, Noda SE, Sato H, Tamaki T, Kiyohara H, Ando K, Nakano T.
Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.
J Radiat Res. 2012 Dec 14. [Epub ahead of print], 2012
Yoshida Y, Suzuki Y, Al-Jahdari WS, Hamada N, Funayama T, Shirai K, Katoh H, Sakashita T, Kobayashi Y, Nakano T.
Evaluation of the relative biological effectiveness of carbon ion beams in the cerebellum using the rat organotypic slice culture system.
J Radiat Res. 53(1):87-92, 2012
Tamaki T, Ishikawa H, Takahashi T, Tamaki Y, Kitamoto Y, Okamoto M, Noda SE, Katoh H, Shirai K, Sakurai H, Nakano T.
Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Brachytherapy. Mar-Apr;11(2):130-6, 2012
Perry J, Okamoto M, Guiou M, Shirai K, Errett A, Chakravarti A.
Novel therapies in glioblastoma.
Neurol Res Int. 2012:428565, 2012
Jacob NK, Cooley JV, Shirai K, Chakravarti A.
Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation.
Onco Targets Ther. 2012;5:7-20, 2012
Okonogi N, Ebara T, Ishikawa H, Yoshida D, Ueno M, Maeno T, Suga T, Nakano T.
A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report.
J Med Case Rep. Dec 28;6(1):427, 2012
Shirai K, Nakagawa A, Abe T, Kawahara M, Saitoh J, Ohno T, Nakano T.
Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.
Int J Mol Imaging. 2012:609545, 2012